What Is 17β-Hydroxysteroid dehydrogenase 2

Overview

17β-Hydroxysteroid dehydrogenase 2 (HSD17B2) is a critical enzyme involved in steroid hormone metabolism. It functions primarily to deactivate potent sex hormones, helping maintain hormonal balance across various tissues in the human body.

Unlike its isoform HSD17B1, which activates hormones, HSD17B2 reduces biological activity by oxidizing 17β-hydroxysteroids. This regulatory role makes it essential in reproductive health, fetal development, and hormone-sensitive tissues.

• Estradiol inactivation: HSD17B2 converts estradiol (E2) to estrone (E1), reducing estrogenic potency by up to 80% in target tissues such as the endometrium.
• Testosterone regulation: The enzyme oxidizes testosterone to androstenedione, decreasing androgenic activity and preventing excessive stimulation in tissues like the prostate.
• Placental expression: During pregnancy, HSD17B2 is highly expressed in the placenta, where it protects the fetus from high maternal estrogen levels by inactivating estradiol.
• Tissue-specific function: High levels are found in the liver, endometrium, and kidney, indicating its role in systemic and local hormone control.
• Gene location: The HSD17B2 gene is located on chromosome 16q22.1, and spans approximately 30 kb with multiple exons regulating tissue-specific expression.

How It Works

HSD17B2 functions at the molecular level by catalyzing redox reactions on steroid hormones using NAD+ as a cofactor. Its enzymatic activity ensures that active sex hormones are converted to less potent forms, particularly in hormone-sensitive environments.

• Enzyme class:HSD17B2 belongs to the short-chain dehydrogenase/reductase (SDR) superfamily and requires NAD+ as a cofactor for oxidation reactions.
• Substrate specificity: It preferentially acts on estradiol and testosterone, converting them to estrone and androstenedione, respectively, with a Km of ~0.5 μM for estradiol.
• Reaction direction: Unlike HSD17B1, which reduces steroids, HSD17B2 primarily performs oxidation, making it a key inactivator of sex hormones.
• pH optimum: The enzyme functions optimally at a pH of 9.0, which is higher than most cellular environments, suggesting regulation by local conditions.
• Protein structure: The human HSD17B2 protein consists of 368 amino acids and forms a homodimer, critical for its catalytic efficiency.
• Regulation by hormones: Expression is upregulated by progesterone in the endometrium, especially during the secretory phase of the menstrual cycle.

Key Comparison

This comparison highlights the opposing roles of HSD17B2 and HSD17B1 in steroid metabolism. While both enzymes modulate sex hormone activity, HSD17B2 acts as a protective inactivator, whereas HSD17B1 enhances hormonal signaling, particularly in reproductive tissues.

Key Facts

Understanding the biochemical and physiological significance of HSD17B2 involves examining its genetic, enzymatic, and clinical characteristics. These facts underscore its importance in endocrinology and reproductive medicine.

• Cloning date: The gene was first cloned in 1994 by M. M. Peltoketo et al., marking a milestone in steroid enzyme research.
• Gene size: The HSD17B2 gene spans 30 kilobases on chromosome 16 and includes multiple regulatory regions.
• Expression peak: In the endometrium, expression increases 5-fold during the secretory phase due to progesterone stimulation.
• Disease link: Reduced HSD17B2 activity is associated with endometriosis and endometrial hyperplasia due to local estrogen excess.
• Species conservation: The enzyme is highly conserved, with 92% amino acid similarity between human and mouse forms.
• Therapeutic potential: Targeting HSD17B2 may help treat hormone-dependent cancers, with research ongoing since 2005.

Why It Matters

HSD17B2 plays a vital role in maintaining hormonal homeostasis, with implications for fertility, pregnancy, and cancer. Its ability to modulate active sex hormone levels makes it a key player in both normal physiology and disease.

• Fetal protection: In the placenta, HSD17B2 prevents high maternal estradiol from crossing into fetal circulation, reducing developmental risks.
• Endometrial health: By inactivating estrogen, it helps prevent endometrial overgrowth and lowers cancer risk.
• Liver detoxification: The liver uses HSD17B2 to metabolize circulating sex hormones, contributing to systemic hormone clearance.
• Hormone therapy relevance: Understanding its function improves hormone replacement therapy safety by predicting tissue-specific hormone exposure.
• Cancer research: Altered HSD17B2 expression is observed in breast and prostate cancers, suggesting diagnostic or therapeutic value.

Continued research into HSD17B2 may lead to targeted treatments for endocrine disorders, emphasizing its importance in modern medicine.